Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lisa Zimmer
601  Ergebnisse:
Personensuche X
?
1

Shortened progression free and overall survival to immune-c..:

Jansen, Philipp ; Galetzka, Wolfgang ; Lodde, Georg C....
European Journal of Cancer.  208 (2024)  - p. 114208 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Effects of an immunosuppressive therapy on the efficacy of ..:

Kochanek, Corinna ; Gilde, Catharina ; Zimmer, Lisa...
European Journal of Cancer.  198 (2024)  - p. 113508 , 2024
Link: https://doi.org/10.1016/..
 
?
3

The RANKL inhibitor denosumab in combination with dual chec..:

Schaper-Gerhardt, Katrin ; Gutzmer, Ralf ; Angela, Yenny...
European Journal of Cancer.  202 (2024)  - p. 113984 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Association of antibiotic treatment with survival outcomes ..:

Chorti, Eleftheria ; Kowall, Bernd ; Hassel, Jessica C....
European Journal of Cancer.  200 (2024)  - p. 113536 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Stringent monitoring can decrease mortality of immune check..:

Wang, Ying ; Ertl, Carolin ; Schmitt, Christina...
Frontiers in Cardiovascular Medicine.  11 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
6

The side effect registry immuno-oncology (SERIO) – A tool f..:

Ertl, Carolin ; Ruf, Theresa ; Mentzer, Dirk...
European Journal of Cancer.  199 (2024)  - p. 113505 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Second-line therapies for steroid-refractory immune-related..:

Ruf, Theresa ; Kramer, Rafaela ; Forschner, Andrea...
European Journal of Cancer.  203 (2024)  - p. 114028 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Clinical and genetic characteristics of BAP1-mutated non-uv..:

Matull, Johanna ; Placke, Jan-Malte ; Lodde, Georg...
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
9

Outcomes of patients with resected stage III/IV acral or mu..:

Jacques, Sarah K. ; McKeown, Janet ; Grover, Piyush...
European Journal of Cancer.  199 (2024)  - p. 113563 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Case report: Durable complete response of a mucosal melanom..:

Krueger, Oskar ; Eisenburger, Robin ; Tasdogan, Alpaslan...
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
11

Management of infliximab refractory immune checkpoint inhib..:

Harvey, Catriona ; Nahar, Kazi J ; McKeown, Janet...
Journal for ImmunoTherapy of Cancer.  12 (2024)  1 - p. e008232 , 2024
Link: https://doi.org/10.1136/..
 
?
12

Influence of adjuvant therapies on organ‐specific recurrenc..:

Wohlfeil, Sebastian A. ; Kranzmann, Leonie ; Weiß, Christel...
International Journal of Cancer.  , 2024
Link: https://doi.org/10.1002/..
 
?
13

Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) aft..:

Albrecht, Lea Jessica ; Dimitriou, Florentia ; Grover, Piyush...
European Journal of Cancer.  202 (2024)  - p. 113976 , 2024
Link: https://doi.org/10.1016/..
 
?
14

The features and management of acquired resistance to PD1-b..:

Hepner, Adriana ; Versluis, Judith M. ; Wallace, Roslyn...
European Journal of Cancer.  196 (2024)  - p. 113441 , 2024
Link: https://doi.org/10.1016/..
 
?
15

Efficacy and safety of 'Second Adjuvant' therapy with BRAF/..:

Taylor, Amelia M. ; McKeown, Janet ; Dimitriou, Florentia...
European Journal of Cancer.  199 (2024)  - p. 113561 , 2024
Link: https://doi.org/10.1016/..
 
1-15